Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOVAR (Société de valorisation des applications de la recherche) was a Quebec-based technology transfer and valorization organization dedicated to commercializing research from Université Laval and its affiliated health centers. The company provided intellectual property management, seed funding, and business development expertise to transform academic discoveries into viable commercial products, particularly in the life sciences and medtech sectors. SOVAR was instrumental in launching numerous startups and licensing technologies to global pharmaceutical and medical device companies. In April 2021, SOVAR was merged with Aligo Innovation and Univalor to form Axelys, a centralized provincial agency for research commercialization in Quebec. During its operation, it managed a diverse portfolio of innovations ranging from novel therapeutics to advanced diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SOVAR.